Amendment dated March 5, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018

Contract Categories: Business Finance - Note Agreements
EX-10.3 2 ex_137069.htm EXHIBIT 10.3 ex_137069.htm

Exhibit 10.3

 

AMENDMENT

TO THE PROMISSORY NOTE AND WARRANT DATED SEPTEMBER 19, 2018

 

The parties entered into a 12% Promissory Note dated September 19, 2018 in the Original Principal Amount of $280,000, instrument number 33146, (the “Note”), by and between BioLargo, Inc. (the “Issuer”) and Vernal Bay Investments, LLC (the “Holder”) (together referred to as the “Parties”). All capitalized terms not otherwise defined herein have the meaning set forth in the Note.

 

WHEREAS, the Note’s original Maturity Date was January 5, 2019, and pursuant to the terms thereof, on January 3, 2019, Issuer notified Holder of its election to extend the Maturity Date by 60 days to March 6, 2019, and in doing so the Principal Amount due under the Note increased as of January 3, 2019 to $308,000.

 

WHEREAS, the Parties have agreed to further extend the Maturity Date of the Note as set forth herein.

 

The Parties hereby agree to amend the Note as follows:

 

Maturity: The Maturity Date of the Note shall be extended to June 6, 2019.

 

Optional Extension of June 6, 2019 Maturity Date. So long as an Event of Default (as defined in Section 4 of the Note) has not occurred, Issuer may extend the Maturity Date of the Note to September 6, 2019 by giving written notice to Holder at any time prior to the Maturity Date, and in such event the then outstanding Principal Amount of the Note will increase by ten percent (10%), effective as of the date of the notice.

 

Interest Rate: Effective as of March 7, 2019, the Note shall earn interest at the rate of eighteen percent (18%) per annum. For the purpose of clarity, all interest accrued prior to March 7, 2019 accrued at 12% per annum.

 

Amendment to Warrant: Issuer issued to Holder a warrant to purchase 1,387,500 shares of Issuer’s common stock, instrument number 33147, expiring September 19, 2023 (the “Warrant”). As additional consideration for the extension, the Exercise Price of the Warrant (as that term is defined in the Warrant) is hereby reduced from $0.25 to $0.20, and the number of share purchasable under the Warrant is hereby increased from 1,387,500 to 1,734,375 shares.

 

ALL OTHER TERMS AND CONDITIONS OF THE NOTE AND WARRANT REMAIN IN FULL FORCE AND EFFECT.

 

Please indicate acceptance and approval of this amendment dated March 5, 2019 by signing below:

 

/s/Dennis P. Calvert   /s/Robert E. Boyer  
Dennis P. Calvert    Robert E. Boyer  
BioLargo, Inc.   Vernal Bay Investments, LLC  
Chief Executive Officer    Member  
Date signed: March 5, 2019   Date signed: March 6, 2019